Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo

被引:39
作者
Van Valckenborgh, E
De Raeve, H
Devy, L
Blacher, S
Munaut, C
Noël, A
Van Marck, E
Van Riet, I
Van Camp, B
Vanderkerken, K
机构
[1] Free Univ Brussels, Dept Haematol & Immunol, B-1090 Brussels, Belgium
[2] Univ Antwerp Hosp, Dept Pathol, B-2650 Edegem, Belgium
[3] Univ Liege, Lab Tumor & Dev Biol, B-4000 Liege, Belgium
关键词
multiple myeloma; angiogenesis; rat aortic ring assay; MVD;
D O I
10.1038/sj.bjc.6600137
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Multiple myeloma is a B cell malignancy. Recently, it has been demonstrated that bone marrow samples of patients with multiple myeloma display an enhanced angiogenesis. The mechanisms involved seem to be multiple and complex. We here demonstrate that the murine 5T multiple myeloma models are able to induce angiogenesis in vitro by using a rat aortic ring assay and in vivo by determining the microvessel density. The rat aortic rings cultured in 5T multiple myeloma conditioned medium exhibit a higher number of longer and more branched microvessels than the rings cultured in control medium. In bone marrow samples from 5T multiple myeloma diseased mice, a statistically significant increase of the microvessel density was observed when compared to bone marrow samples from age-matched controls. The angiogenic phenotype of both 5T multiple myeloma cells could be related, at least in part, to their capacity to produce vascular endothelial growth factor. These data clearly demonstrate that the 5T multiple myeloma models are good models to study angiogenesis in multiple myeloma and will allow to unravel the mechanisms of neovascularisation, as well as to test new putative inhibitors of angiogenesis. (C) 2002 Cancer Research UK.
引用
收藏
页码:796 / 802
页数:7
相关论文
共 41 条
  • [1] Asosingh K, 2000, Hematol J, V1, P351, DOI 10.1038/sj.thj.6200052
  • [2] Barillé S, 1999, J IMMUNOL, V163, P5723
  • [3] Metalloproteinases in multiple myeloma: Production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells
    Barille, S
    Akhoundi, C
    Collette, M
    Mellerin, MP
    Rapp, MJ
    Harousseau, JL
    Bataille, R
    Amiot, M
    [J]. BLOOD, 1997, 90 (04) : 1649 - 1655
  • [4] Bellamy WT, 1999, CANCER RES, V59, P728
  • [5] The thin red line: Angiogenesis in normal and malignant hematopoiesis
    Bertolini, F
    Mancuso, P
    Gobbi, A
    Pruneri, G
    [J]. EXPERIMENTAL HEMATOLOGY, 2000, 28 (09) : 993 - 1000
  • [6] Improved quantification of angiogenesis in the rat aortic ring assay
    Blacher S.
    Devy L.
    Burbridge M.F.
    Roland G.
    Tucker G.
    Noël A.
    Foidart J.-M.
    [J]. Angiogenesis, 2001, 4 (2) : 133 - 142
  • [7] Carmeliet P, 2000, ANN NY ACAD SCI, V902, P249
  • [8] CLAFFEY KP, 1992, J BIOL CHEM, V267, P16317
  • [9] Compagni A, 2000, BRIT J CANCER, V83, P1
  • [10] TUMOR VASCULAR-PERMEABILITY FACTOR STIMULATES ENDOTHELIAL-CELL GROWTH AND ANGIOGENESIS
    CONNOLLY, DT
    HEUVELMAN, DM
    NELSON, R
    OLANDER, JV
    EPPLEY, BL
    DELFINO, JJ
    SIEGEL, NR
    LEIMGRUBER, RM
    FEDER, J
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) : 1470 - 1478